SEPTInvestingStart Free

STOK SCHEDULE 13G/A: SEC filing

Morgan Stanley

Filed with the SEC on · accession 0000895421-26-000321

STOK filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. Morgan Stanley filed an amended Schedule 13G/A disclosing that, as of the filing date, it and its subsidiary Morgan Stanley Capital Services LLC have ceased to be beneficial owners of more than 5% of Stoke Therapeutics common stock, with Morgan Stanley reporting 4.9% and MS Capital Services… The stock moved +1.8% by the first close after the filing.

Summary of the filing

Morgan Stanley filed an amended Schedule 13G/A disclosing that, as of the filing date, it and its subsidiary Morgan Stanley Capital Services LLC have ceased to be beneficial owners of more than 5% of Stoke Therapeutics common stock, with Morgan Stanley reporting 4.9% and MS Capital Services reporting 4.1%.

For details, click here →

Key details

Filer / parent holding companyMorgan Stanley
Wholly-owned subsidiary of morgan stanley and reporting entityMorgan Stanley Capital Services LLC
Issuer / subject companyStoke Therapeutics, Inc.
Authorized signatory, morgan stanleyClaire Gordon

How STOK stock reacted

Close before

$26.20

Nov 12, 2026

First close after

+1.83%

$26.68

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for STOK, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for STOK?

Click here

Frequently asked questions

What did STOK file with the SEC on Nov 13, 2026?

STOK filed a SCHEDULE 13G/A (SEC filing). Morgan Stanley filed an amended Schedule 13G/A disclosing that, as of the filing date, it and its subsidiary Morgan Stanley Capital Services LLC have ceased to be beneficial owners of more than 5% of Stoke Therapeutics common stock, with Morgan Stanley reporting 4.9% and MS Capital Services reporting 4.1%.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did STOK stock react to this filing?

STOK closed at $26.20 before the filing and $26.68 on Nov 13, 2026 (+1.83%).

Other STOK SEC filings

Get alerts when STOK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
STOK overviewSTOK analysisSTOK newsLatest SEC filings